Literature DB >> 19126436

Association of antiepileptic drug nonadherence with risk of seizures in adults with epilepsy.

Ranjani Manjunath1, Keith L Davis, Sean D Candrilli, Alan B Ettinger.   

Abstract

This study evaluated the potential effect of antiepileptic drug (AED) nonadherence on the risk of subsequent seizure. Retrospective insurance claims from the United States were analyzed. Inclusion criteria were: age 21-64 years, diagnosis of epilepsy or nonfebrile convulsions, 2 AED prescriptions, and insurance enrollment for 6 months pre- and 60 days post-AED initiation. Seizure was defined as a hospital or emergency admission associated with epilepsy or nonfebrile convulsions. Observation began 7 days post-drug initiation, ending with the first of the following: seizure, insurance disenrollment, or 365 days post-drug initiation. Adherence was measured using the medication possession ratio (MPR), with MPR <0.8 defining nonadherence. Seizure risk was assessed using an extended Cox proportional hazards model. Of 18,073 subjects identified, 2467 (14%) had 1 seizure. Mean follow-up was 133 days among subjects with event and 305 days for patients without event. Seizure risk was 21% higher among nonadherers (hazard ratio=1.205, P=0.0002) than adherers.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19126436     DOI: 10.1016/j.yebeh.2008.12.006

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  37 in total

Review 1.  Strategies for improving adherence to antiepileptic drug treatment in people with epilepsy.

Authors:  Sinaa Al-Aqeel; Olga Gershuni; Jawza Al-Sabhan; Mickael Hiligsmann
Journal:  Cochrane Database Syst Rev       Date:  2017-02-03

2.  A mixed methods analysis of support for self-management behaviors: perspectives of people with epilepsy and their support providers.

Authors:  Elizabeth Reisinger Walker; George Engelhard; Christina Barmon; Robin E McGee; Claire E Sterk; Colleen Diiorio; Nancy J Thompson
Journal:  Epilepsy Behav       Date:  2014-01-08       Impact factor: 2.937

3.  White coat adherence over the first year of therapy in pediatric epilepsy.

Authors:  Avani C Modi; Lisa M Ingerski; Joseph R Rausch; Tracy A Glauser; Dennis Drotar
Journal:  J Pediatr       Date:  2012-05-18       Impact factor: 4.406

4.  High health care costs in minority groups of older US Medicare beneficiaries with epilepsy.

Authors:  Maria Pisu; Joshua Richman; Jerzy P Szaflarski; Ellen Funkhouser; Chen Dai; Lucia Juarez; Edward Faught; Roy C Martin
Journal:  Epilepsia       Date:  2019-06-06       Impact factor: 5.864

5.  Development and reliability of a correction factor for parent-reported adherence to pediatric antiepileptic drug therapy.

Authors:  Avani C Modi; Shanna M Guilfoyle; Diego A Morita; Tracy A Glauser
Journal:  Epilepsia       Date:  2010-11-18       Impact factor: 5.864

6.  Adherence to antiepileptic drugs among diverse older Americans on Part D Medicare.

Authors:  Kendra Piper; Joshua Richman; Edward Faught; Roy Martin; Ellen Funkhouser; Jerzy P Szaflarski; Chen Dai; Lucia Juarez; Maria Pisu
Journal:  Epilepsy Behav       Date:  2016-12-27       Impact factor: 2.937

Review 7.  The long-term safety of antiepileptic drugs.

Authors:  Athanasios Gaitatzis; Josemir W Sander
Journal:  CNS Drugs       Date:  2013-06       Impact factor: 5.749

8.  Factors associated with seizure recurrence in epilepsy patients treated with antiepileptic monotherapy: A retrospective observational cohort study using US administrative insurance claims.

Authors:  Natalia Shcherbakova; Karen Rascati; Carolyn Brown; Kenneth Lawson; Suzanne Novak; Kristin M Richards; Linda Yoder
Journal:  CNS Drugs       Date:  2014-11       Impact factor: 5.749

9.  The effect of poor compliance on the pharmacokinetics of carbamazepine and its epoxide metabolite using Monte Carlo simulation.

Authors:  Jun-jie Ding; Yun-jian Zhang; Zheng Jiao; Yi Wang
Journal:  Acta Pharmacol Sin       Date:  2012-10-29       Impact factor: 6.150

Review 10.  A Clinician's Guide to Oral Extended-Release Drug Delivery Systems in Epilepsy.

Authors:  James W Wheless; Stephanie J Phelps
Journal:  J Pediatr Pharmacol Ther       Date:  2018 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.